Differential suppression of epidermal antimicrobial protein expression in atopic dermatitis and in EFAD mice by pimecrolimus compared to corticosteroids
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differential suppression of epidermal antimicrobial protein expression in atopic dermatitis and in EFAD mice by pimecrolimus compared to corticosteroids
Authors
Keywords
-
Journal
EXPERIMENTAL DERMATOLOGY
Volume 20, Issue 10, Pages 783-788
Publisher
Wiley
Online
2011-06-30
DOI
10.1111/j.1600-0625.2011.01322.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Differential expression of antimicrobial peptides in margins of chronic wounds
- (2010) Stefanie Dressel et al. EXPERIMENTAL DERMATOLOGY
- The role of antibacterial therapy in atopic eczema
- (2010) Christina Schnopp et al. EXPERT OPINION ON PHARMACOTHERAPY
- Enhanced Expression and Secretion of Antimicrobial Peptides in Atopic Dermatitis and after Superficial Skin Injury
- (2010) Jürgen Harder et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Mechanical and Metabolic Injury to the Skin Barrier Leads to Increased Expression of Murine β-Defensin-1, -3, and -14
- (2010) Kerstin Ahrens et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Changes of Antimicrobial Peptides and Transepidermal Water Loss After Topical Application of Tacrolimus and Ceramide-dominant Emollient in Patients with Atopic Dermatitis
- (2010) Kui Young Park et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Enhanced expression of the antimicrobial peptide LL-37 in lesional skin of adults with atopic eczema
- (2009) N. Ballardini et al. BRITISH JOURNAL OF DERMATOLOGY
- Isolation of α-toxin-producingStaphylococcus aureusfrom the skin of highly sensitized adult patients with severe atopic dermatitis
- (2009) K. Wichmann et al. BRITISH JOURNAL OF DERMATOLOGY
- Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial
- (2009) D.Y.M. Leung et al. BRITISH JOURNAL OF DERMATOLOGY
- Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma
- (2009) P. Bhavsar et al. EUROPEAN RESPIRATORY JOURNAL
- Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function
- (2009) Minjeong Kim et al. EXPERIMENTAL DERMATOLOGY
- Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis
- (2009) Jens-Michael Jensen et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- RNase 7 Contributes to the Cutaneous Defense against Enterococcus faecium
- (2009) Bente Köten et al. PLoS One
- Mouse Beta-Defensin-14, an Antimicrobial Ortholog of Human Beta-Defensin-3
- (2008) K. Hinrichsen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Microanalysis of an antimicrobial peptide, β-defensin-2, in the stratum corneum from patients with atopic dermatitis
- (2008) S. Asano et al. BRITISH JOURNAL OF DERMATOLOGY
- Differential mRNA Expression of Antimicrobial Peptides and Proteins in Atopic Dermatitis as Compared to Psoriasis Vulgaris and Healthy Skin
- (2008) Thilo Gambichler et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Pimecrolimus Enhances TLR2/6-Induced Expression of Antimicrobial Peptides in Keratinocytes
- (2008) Amanda S. Büchau et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Antimicrobial Protein Psoriasin (S100A7) Is Upregulated in Atopic Dermatitis and after Experimental Skin Barrier Disruption
- (2008) Regine Gläser et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Co-Regulation and Interdependence of the Mammalian Epidermal Permeability and Antimicrobial Barriers
- (2007) Karin M. Aberg et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started